Steven Mintz - Jan 8, 2024 Form 3 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director
Signature
/s/ Steven Mintz
Stock symbol
AGE
Transactions as of
Jan 8, 2024
Transactions value $
$0
Form type
3
Date filed
1/18/2024, 05:29 PM
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGE Common Stock, $0.0001 par value 116K Jan 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AGE Option to Purchase Common Stock Jan 8, 2024 Common Stock 63.8K $0.38 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held in joint accounts with adult children.
F2 Stock options will vest in quarterly installments based upon Mr. Mintz's continued service as a director, with options to purchase 15,006 shares scheduled to vest on March 31,2024 and options to purchase 16,250 shares scheduled to vest on each of the following dates: June 30, 2024, September 30, 2024, and December 31, 2024.